NCT05320926View on ClinicalTrials.gov

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

NARecruitingINTERVENTIONAL
Enrollment

3,744

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

July 10, 2028

Study Completion Date

July 10, 2028

Conditions
Ischemic Heart Disease
Interventions
DRUG

Clopidogrel monotherapy

Patients will be randomized to stop aspirin and maintain clopidogrel after short-term DAPT.

DRUG

Aspirin monotherapy

Patients will be randomized to stop clopidogrel and maintain aspirin after short-term DAPT.

DEVICE

zotarolimus-eluting stent (Resolute Onyx ®)

zotarolimus-eluting stent (Resolute Onyx ®)

Trial Locations (1)

Unknown

RECRUITING

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER